S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
Top-Rated StocksTop-Rated

Legend Biotech (LEGN) Earnings Date, Estimates & Call Transcripts

$59.28
-2.14 (-3.48%)
(As of 12/8/2023 ET)
Compare
Today's Range
$58.65
▼
$61.74
50-Day Range
$57.25
▼
$69.74
52-Week Range
$42.90
▼
$77.32
Volume
1.12 million shs
Average Volume
1.13 million shs
Market Capitalization
$10.78 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$83.61
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Apr. 4Estimated
Actual EPS
(Nov. 20)
-$0.17 Beat By $0.14
Consensus EPS
(Nov. 20)
-$0.31
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LEGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LEGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Legend Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.49)($0.24)($0.38)
Q2 20234($0.78)($0.34)($0.54)
Q3 20234($0.84)($0.15)($0.51)
Q4 20234($0.67)($0.16)($0.43)
FY 202315($2.78)($0.89)($1.86)
Q1 20242($0.62)$0.14($0.24)
Q2 20242($0.62)$0.08($0.27)
Q3 20242($0.54)($0.13)($0.34)
Q4 20242($0.54)$0.12($0.21)
FY 20248($2.32)$0.21($1.06)

LEGN Earnings Date and Information

Legend Biotech last released its earnings results on November 20th, 2023. The reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.31) by $0.14. The business earned $96 million during the quarter, compared to analyst estimates of $97.25 million. Its revenue was up 250.4% compared to the same quarter last year. Legend Biotech has generated $0.00 earnings per share over the last year. Earnings for Legend Biotech are expected to grow in the coming year, from ($2.50) to ($1.67) per share. Legend Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates.

Legend Biotech Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/4/2024
Estimated)		------- 
11/20/2023Q3 2023($0.31)($0.17)+$0.14($0.17)$97.25 million$96.00 million    
8/15/2023Q2 2023($0.36)($0.57)($0.21)$0.03$56.64 million$73.30 million
5/18/2023Q1 2023($0.56)($0.40)+$0.16($0.46)$37.06 million$36.34 million
2/17/2023Q2 2022-($0.41)($0.41)($0.20)-$11.97 million
6/1/2022Q1 2022($0.37)($0.24)+$0.13($0.35)$46.67 million$40.83 million
3/18/2022Q4 2021($0.35)($0.38)($0.03)($0.46)$13.23 million$39.00 million
11/16/2021Q3 2021($0.35)($0.43)($0.08)($0.43)$12.50 million$16.88 million
8/22/2021Q2 2021($0.34)($0.64)($0.30)($0.31)$12.50 million$20.23 million
5/17/2021Q1 2021($0.35)($0.30)+$0.05($0.30)$12.50 million$13.68 million
3/17/2021Q4 2020($0.28)($0.22)+$0.06($0.22)$12.88 million$40.78 million  












Legend Biotech Earnings - Frequently Asked Questions

When is Legend Biotech's earnings date?

Legend Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off last year's report dates. Learn more on LEGN's earnings history.

Did Legend Biotech beat their earnings estimates last quarter?

In the previous quarter, Legend Biotech (NASDAQ:LEGN) reported ($0.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.14. Learn more on analysts' earnings estimate vs. LEGN's actual earnings.

How can I listen to Legend Biotech's earnings conference call?

The conference call for Legend Biotech's latest earnings report can be listened to online. Listen to Conference Call

How can I read Legend Biotech's conference call transcript?

The conference call transcript for Legend Biotech's latest earnings report can be read online. Read Transcript

How much revenue does Legend Biotech generate each year?

Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $233.31 million.

How much profit does Legend Biotech generate each year?

Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$446.35 million. LEGN has generated $0.00 earnings per share over the last four quarters.

What is Legend Biotech's EPS forecast for next year?

Legend Biotech's earnings are expected to grow from ($2.50) per share to ($1.67) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:LEGN) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -